Cited by 40Syphilis Diagnosis and TreatmentBacterial Identification and Susceptibility TestingBiosensors and Analytical Detection

Clinical test performance of a rapid point-of-care syphilis treponemal antibody test: a systematic review and meta-analysis.

Open access
Bristow, Claire C, Klausner, Jeffrey D, Tran, Anthony·2020·Clinical Infectious Diseases

Abstract

We reviewed relevant syphilis diagnostic literature and conducted a meta-analysis to address the question, "What is the sensitivity and specificity of the Syphilis Health Check, a rapid qualitative test for the detection of human antibodies to Treponema pallidum." The Syphilis Health Check is the only rapid syphilis test currently cleared by the Food and Drug Administration (FDA). We conducted a systematic review and a meta-analysis using Bayesian bivariate random-effects and fixed-effect models to create pooled estimates of sensitivity and specificity of the Syphilis Health Check. We identified 5 test evaluations published in the literature and 10 studies submitted to the FDA and for a Clinical Laboratory Improvement Amendments waiver application. The pooled sensitivity (95% CI) from the laboratory evaluations (n = 5) was 98.5% (92.1-100%), while pooled specificity was 95.9% (81.5-100.0%). The pooled sensitivity for prospective studies (n = 10) was 87.7% ( 71.8-97.2%), while pooled specificity was 96.7% (91.9-99.2%). Using nontreponemal supplemental testing, the sensitivity improved to a pooled sensitivity of 97.0% (94.8-98.6%). The Syphilis Health Check may provide accurate detection of treponemal antibody.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/cid/ciaa350

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A presumptive diagnosis of syphilis requires use of two laboratory serologic tests: a nontreponemal test and a treponemal test.

    “A presumptive diagnosis of syphilis requires use of two laboratory serologic tests: a nontreponemal test (i.e., Venereal Disease Research Laboratory [VDRL] or rapid plasma reagin [RPR] test) and a treponemal test”

    From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [568]

    The Abstract says treponemal rapid tests cannot determine whether infection is current and that nontreponemal testing is recommended in some settings. The Results describe diagnostic algorithms using both RPR and a treponemal test. Neither passage establishes a universal requirement for two laboratory tests for a presumptive diagnosis; the paper also discusses treponemal testing outside laboratory settings. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Bristow, C. C., Klausner, J. D., & Tran, A.
Affiliations
  • University of California San Diego (US)
  • University of California, Los Angeles (US)
  • District of Columbia Department of Forensic Sciences (US)
Corresponding author
Bristow, Claire C
Venue
Clinical Infectious Diseases
Published
2020-06-24
Volume
71
Issue
Supplement_1
Pages
S52-S57
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W3037173893
Cited by
40
References
19
Citations by year
2026: 7 · 2025: 5 · 2024: 9 · 2023: 4 · 2022: 4 · 2021: 7 · 2020: 3 · 2019: 1
FWCI
0.57
Type
journal article
Language
en
Open access
Locations
  • Clinical Infectious Diseases (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
National Institutes of Health (K01 AI136725, T32 AI007384, P30 AI028697, P30 MH058107)
Topics
  • Health Sciences › Medicine › Physiology › Syphilis Diagnosis and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Bacterial Identification and Susceptibility Testing
  • Physical Sciences › Engineering › Biomedical Engineering › Biosensors and Analytical Detection
Keywords
syphilis, Treponema pallidum, treponemal antibodies, point-of-care testing, rapid diagnostic tests, diagnostic sensitivity, diagnostic specificity, FDA clearance
MeSH terms
Antibodies, Bacterial, Bayes Theorem, Humans, Prospective Studies, Sensitivity and Specificity, Syphilis, Syphilis Serodiagnosis, Treponema pallidum, Point-of-Care Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review